| Income Statement |
| Total Revenue | 197.82M |
|
| Revenues (USD) | 197.82M |
| Cost of Revenue | 59.03M |
| Gross Profit | 138.79M |
| Operating Expenses | 106.92M |
| Research and Development Expense | 16.96M |
| Selling, General and Administrative Expense | 80.58M |
| Operating Income | 31.87M |
| Income Tax Expense | 3.55M |
| Net Income | 6.86M |
| Net Income Common Stock | 6.86M |
| Net Income Common Stock (USD) | 6.86M |
| Consolidated Income | 6.86M |
| Earnings per Basic Share | 0.19 |
| Earnings per Basic Share (USD) | 0.19 |
| Earnings per Diluted Share | 0.19 |
| Earning Before Interest & Taxes (EBIT) | 10.41M |
| Earning Before Interest & Taxes (USD) | 10.41M |
| Weighted Average Shares | 36.53M |
| Weighted Average Shares Diluted | 36.58M |
| Balance Sheet |
| Cash and Equivalents | 173.17M |
| Cash and Equivalents (USD) | 173.17M |
| Trade and Non-Trade Receivables | 63.69M |
| Current Assets | 330.40M |
| Property, Plant & Equipment Net | 49.13M |
| Total Assets | 1.13B |
| Debt Current | 1.54M |
| Total Debt | 6.31M |
| Current Liabilities | 146.26M |
| Debt Non-Current | 4.77M |
| Total Liabilities | 186.95M |
| Accumulated Retained Earnings (Deficit) | 456.03M |
| Accumulated Other Comprehensive Income | -4.02M |
| Shareholders Equity | 938.48M |
| Shareholders Equity (USD) | 938.48M |
| Assets Non-Current | 795.03M |
| Total Debt (USD) | 6.31M |
| Deferred Revenue | 85.59M |
| Goodwill and Intangible Assets | 711.86M |
| Liabilities Non-Current | 40.69M |
| Trade and Non-Trade Payables | 9.48M |
| Tax Assets | 514.00K |
| Tax Liabilities | 30.93M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 15.53M |
| Net Cash Flow from Financing | -47.31M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 18.90M |
| Capital Expenditure | 170.00K |
| Issuance (Purchase) of Equity Shares | -47.31M |
| Net Cash Flow from Investing | 170.00K |
| Net Cash Flow from Operations | 66.03M |
| Effect of Exchange Rate Changes on Cash | 6.00K |
| Share Based Compensation | 18.70M |